SubHero Banner

Fresenius Kabi – FDA authorizes foreign importation of cisplatin

October 12, 2023 - Cisplatin has been a shortage since February 2023 due to increased demand. To bolster supply, the Food and Drug Administration (FDA) is providing Fresenius Kabi with special authorization to temporarily import their cisplatin product, Kemoplat, into the U.S. This product is not a FDA-approved product but is being given special authorization due to the shortage.

Download PDF